ValueAct Capital Master Fund, L.P.: News Release Sep 4, 2009
SAN FRANCISCO, CALIFORNIA--(Marketwire - Sept. 3, 2009) - ValueAct Capital Master Fund, L.P. announced today that it has entered into an agreement with a subsidiary of Danaher Corporation pursuant to which it has agreed to vote its common shares in MDS Inc., in favour of the purchase of MDS Analytical Technologies business by Danaher, as more fully described in the attached Early Warning Report ... Pursuant to the terms of the Support Agreement, ValueAct Master Fund made certain representations... (CCNMatthews Press Releases)
Analyst Picks and Pans: Apple, Danaher, Franklin Resources Sep 4, 2009
1 billion, including debt, for two businesses, Applied Biosystems/MDS Sciex, a mass spectrometry business, plus a bioresearch and analytical instrumentation company owned by MDS Inc.. Mass spectrometry is a technique widely used in medical research for determining what elements make up a molecule. (BusinessWeek)
Canada minister staying despite nuclear file slip Jun 5, 2009
Chalk River produces most of the isotopes distributed by MDS Nordion, a subsidiary of Canadian health sciences company MDS Inc. The isotopes are used in medical tests and cancer treatments. The revelation about the mislaid nuclear documents was doubly embarrassing for the Conservative government, given that former Foreign Minister Maxime Bernier was forced to resign in May 2008 after leaving secret documents in the apartment of a girlfriend who had ties to organized crime. (Yahoo News)
MDS Announces Strategy to Focus MDS Pharma Services on Early Stage Operations - Discovery Through Phase IIa Jun 1, 2009
By divesting our Phase II-IV operations, we will be better able to take advantage of our core competencies in Early Stage. We believe this will prove beneficial to the success of the business, to customers and to shareholders. (Canada Newswire)
MDS Nordion Opens New Radiopharmaceutical Production Facility in Belgium May 28, 2009
MDS Nordion, a business unit of MDS Inc., is a global leader in providing medical isotopes for molecular and diagnostic imaging, radiotherapeutics and sterilization technologies for medical products that benefit the lives of millions of people in more than 50 countries around the world ... MDS Inc. (TSX: MDS; NYSE: ) is a global life sciences company that provides market-leading products and services that our customers need for the development of drugs, and the diagnosis and treatment of... (PR Newswire)
Sentry Select Capital Inc. Announces Exchange Ratios for Sentry Select Canadian Income Exchange Fund May 16, 2009
5298 ---------------------------------------------------------------------------- MDS Inc. MDS 6. 7322 0. (CCNMatthews Press Releases)
Markets extend rally Mar 13, 2009
Life-sciences company MDS Inc. reported a narrow quarterly profit of $2-million as net revenue fell to $257-million from $296-million. But management expressed optimism after a wrenching writedown and restructuring, and its shares gained 32 cents to $7. (Globe and Mail -- Business)
